Effectiveness of Two Different Body Positions During Facemask Ventilation in Obese Patients

March 19, 2024 updated by: Mount Sinai Hospital, Canada

Effectiveness of Two Different Body Positions During Facemask Ventilation in Class 3 Obesity Patients: a Randomized Crossover Trial

It is important to provide enough oxygen to the patients who are asleep during surgery. One way to do this is by using a mask placed over the face to help them breathe. When it becomes difficult getting enough oxygen into the patient's body using the mask, it's called difficult mask ventilation. There can be different reasons for this, and having a higher BMI is one of them. Body physique is assessed by Body Mass Index (BMI). This calculation gives an indication of a person's weight relative to their height.

There is some evidence in the research literature to suggest that when the patient is positioned in a way that helps their airway, like using a device to lift their head and torso 25 degrees , it might help the process of getting enough oxygen work better. The study aims to determine if patients with high BMI can breathe better using a face mask while they are in a head elevated position compared to lying flat on their back.

Study Overview

Detailed Description

Facemask ventilation is an important technique applied by anesthesiologists after induction of general anesthesia and before tracheal intubation. It is also used as a rescue maneuver in situations where a patient's consciousness is compromised affecting oxygenation. Obesity is well known to be one of the difficult predictors for facemask ventilation. In fact, the occurrence of difficult facemask ventilation is more frequent in obese patients than non obese. One of the maneuvers described to optimize the effectiveness of facemask ventilation in the general population is positioning the patient in a 25 degree head elevated position. A previous study has demonstrated improvement in facemask ventilation in obese patients with BMI from 30 to 40 kg/m2 in the head elevated position, compared to supine. However, it is not yet determined if this is applicable to patients with a BMI above 40 kg/m2. Adult obese patients with BMI of at least 40 kg/m2 will be randomized to be ventilated after induction of general anesthesia via a face mask while in one of the positions: supine or head elevated, while the volume of air that enters and exits the lungs is measured. Participants will then be changed to the second position, ventilated in the same manner and measures obtained again.

Do patients with class 3 obesity positioned in the head elevated position can be better ventilated with a face mask and positive pressure, compared to the supine position?

Study Type

Interventional

Enrollment (Estimated)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • BMI > 40 kg/m2
  • age > 18 years
  • scheduled for elective surgery under general anesthesia
  • have the ability to comprehend the rationale for the study and provide consent

Exclusion Criteria:

  • pregnancy,
  • risk of aspiration of gastric content
  • patients using glucagon-like peptide(GLP)-1 agonists
  • emergency cases
  • upper airway disease or airway anatomical abnormalities
  • presence of major cardiovascular, respiratory, or cerebral vascular disease
  • if the provider anesthesiologist indicates an awake technique to secure the airway

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supine
Participant will be ventilated with facemask while in supine position.
Participant to be ventilated starting 2 minutes after induction of general anesthesia via a face mask while in supine position. Participants will be crossed over to the head elevated position after the first measurement is obtained.
Experimental: Head elevated
Participant will be ventilated with facemask while in head elevated position.
Participant to be ventilated starting 2 minutes after induction of general anesthesia via a face mask while in head elevated position. Participants will be crossed over to the supine position after the first measurement is obtained.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average tidal volume
Time Frame: During induction.
The primary outcome for this trial is the average tidal volume in 10 ventilations in each position, flat or head elevated.
During induction.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictors for difficult mask ventilation like BMI
Time Frame: During induction
Secondary outcome will be: the incidence and correlation of other predictors for difficult mask ventilation like BMI.
During induction
Predictors for difficult mask ventilation like presence of beard
Time Frame: During induction
Secondary outcomes will be: the incidence and correlation of other predictors for difficult mask ventilation like, presence of a beard.
During induction
Predictors for difficult mask ventilation like Mallampati classification III or IV
Time Frame: During induction
Secondary outcomes will be: the incidence and correlation of other predictors for difficult mask ventilation like Mallampati classification III or IV.
During induction
Predictors for difficult mask ventilation like age of 57 yo or older.
Time Frame: During induction
Secondary outcomes will be: the incidence and correlation of other predictors for difficult mask ventilation like, age of 57 yo or older.
During induction
Predictors for difficult mask ventilation like severely limited mandibular protrusion
Time Frame: During induction
Secondary outcomes will be: the incidence and correlation of other predictors for difficult mask ventilation like severely limited mandibular protrusion.
During induction
Predictors for difficult mask ventilation like history of snoring.
Time Frame: During induction
Secondary outcomes will be: the incidence and correlation of other predictors for difficult mask ventilation like history of snoring.
During induction
Oropharyngeal airway
Time Frame: During induction
Incidence of use of an oropharyngeal airway during the protocol.
During induction
Insufficient mask ventilation
Time Frame: During induction.
Incidence of insufficient mask ventilation (defined as tidal volume (Vt) < 4 ml/kg IBW), or failed facemask ventilation defined as absence of End-tidal carbon dioxide(EtCO2) after 3 consecutive ventilations.
During induction.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fabricio Zasso, MD, Mount Sinai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 25, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

February 26, 2024

First Submitted That Met QC Criteria

March 8, 2024

First Posted (Actual)

March 12, 2024

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 23-0150-A

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Head position for face mask ventilation during induction supine

Subscribe